COVID-19 Pandemic in Pakistan

Author:

Ilyas Nasir,Azuine Romuladus E.,Tamiz Alina

Abstract

Since February 26, 2020, when coronavirus disease 2019 (COVID-19) pandemic emerged in Karachi City and rapidly spread throughout Pakistan, the disease has affected more than 6200 people and more than 111 deaths have been reported till April 15. If we compare the disasters of COVID-19 in Pakistan with other countries like China, Iran and European Union nations, so many questions arise. We have so many challenges in controlling this pandemic like the geopolitics of country, poverty, low literacy rate, environmental conditions, hygienic conditions, and food intake habits. In all these aspects, there are poor conditions but the outbreak of COVID-19 in Pakistan was slower than other developing countries. Pakistan’s humid condition, hot weather, early response to COVID-19, population immune system, BCG vaccination and the number of young people favors to attenuate the impact of COVID-19. In this paper, we discuss the outbreak of COVID-19 pandemic in China, Iran and Pakistan and share day-by-day developments in this pandemic. We present the structure of COVID-19 and its similarity with SARSCOV and SARS-COV2. We also discuss the treatment procedure like use of Remdesivir (an adenosine similarity) used against RNA viruses, Chloroquine (extensively used anti-malarial drug), convalescent plasma, neutralizing antibody targeting the ACE-2 receptor and ACE-2-like molecule that might bind to the S protein of the coronavirus and disadvantages of the discussed medications. The impact of COVID-19 in the economics of Pakistan and government reliefs are also discussed. Key words: • Coronavirus • COVID-19 • Pakistan • Pandemic • Outbreak   Copyright © 2020 Ilyas et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Publisher

Global Health and Education Projects, Inc. (GHEP)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3